Metraipolis › archive › dc_e20ea44b1d3b

Targeting DDX3X suppresses progression of KRAS-driven lung cancer by disrupting antioxidative homeostasis and inducing ferroptosis — Europe PMC PMID:40885716

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40885716
DOI
10.1038/s41419-[numero omesso]-8
License (as archived)
solo-consultazione
Archived
2026-11-10T06:28:57.326Z
SHA-256 of the archived text
26b57ff5c7bdf41da44782fc9ad9afcaf75591935aedfa36b47fd367a5776312
Stable URL of this page
https://metraipolis.com/documento/dc_e20ea44b1d3b

How to cite

Targeting DDX3X suppresses progression of KRAS-driven lung cancer by disrupting antioxidative homeostasis and inducing ferroptosis — Europe PMC PMID:40885716 — Europe PMC (en), https://europepmc.org/article/MED/40885716 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e20ea44b1d3b (Metraipolis archive dc_e20ea44b1d3b, sha256 26b57ff5c7bdf41da44782fc9ad9afcaf75591935aedfa36b47fd367a5776312)
BibTeX
@misc{dce20ea44b1d3b,
  title = {Targeting DDX3X suppresses progression of KRAS-driven lung cancer by disrupting antioxidative homeostasis and inducing ferroptosis — Europe PMC PMID:40885716},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40885716},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e20ea44b1d3b; sha256 26b57ff5c7bdf41da44782fc9ad9afcaf75591935aedfa36b47fd367a5776312},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40885716. Agents can read the archived copy with the MCP tool read_document.